Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer

Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.
Latest website image capture
Clouds background image

Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the page. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page.
    Difference
    0.1%
    Check dated 2025-12-23T09:42:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no substantive changes to the study details or layout were detected.
    Difference
    0.0%
    Check dated 2025-12-01T16:58:51.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Publications section wording updated to clarify that entries are automatically filled from PubMed and may not be about the study, and the revision line now shows Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:29:22.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The government funding status notice on the page has been removed.
    Difference
    0.3%
    Check dated 2025-11-17T06:47:57.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page updates are minor editorial changes with no substantive alterations to the study design, endpoints, or enrollment data.
    Difference
    0.3%
    Check dated 2025-11-03T01:15:03.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T10:19:16.000Z thumbnail image

Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer

Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.